| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Renal Physiology, Vol 268, Issue 5 931-F939, Copyright © 1995 by American Physiological Society
ARTICLES |
Y. Sakairi, H. R. Jacobson, T. D. Noland, J. H. Capdevila, J. R. Falck and M. D. Breyer
Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
We examined the mechanism by which the cytochrome P-450 metabolite of arachidonate, 5,6-epoxyeicosatrienoic acid (5,6-EET), modulates electrogenic transport in the rabbit cortical collecting duct (CCD). 5,6-EET depolarized transepithelial voltage (VT) in a concentration-dependent manner with a maximal effect at 1 microM. None of the other EET regioisomers (8,9-, 11,12-, or 14,15-EET; all at 1 microM) affected VT, This action was also stereoselective, with 5(S),6(R)-EET producing a 2.5-fold greater effect on VT than 5(R),6(S)-EET (1 microM each). Like basolateral prostaglandin E2 (PGE2), both luminal and basolateral 5,6-EET increased cytosolic Ca2+ concentration ([Ca2+]i) in the rabbit CCD. Pretreatment with cyclooxygenase inhibitors (10 microM ibuprofen or 5 microM indomethacin) completely blocked both the [Ca2+]i increase and the change in VT. Neither 5,6-epoxy-PGE1 nor 5-hydroxy-PGI1, cyclooxygenase metabolites of 5,6-EET, affected VT. However, when added to primary cultures of rabbit CCDs, 5,6-EET stimulated endogenous PGE2 synthesis. We propose that 5,6-EET stimulates endogenous prostaglandin synthesis, which inhibits electrogenic ion transport in the CCD.
This article has been cited by other articles:
|
|
 |
|
  Z. Wang, Y. Wei, J. R. Falck, K. R. Atcha, and W.-H. Wang Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1441 - F1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jin, Z. Wang, Y. Zhang, B. Yang, and W.-H. Wang PGE2 inhibits apical K channels in the CCD through activation of the MAPK pathway Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1299 - F1307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Nusing, H. Schweer, I. Fleming, D. C. Zeldin, and M. Wegmann Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity Am J Physiol Renal Physiol, July 1, 2007; 293(1): F288 - F298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sun, D.-H. Lin, T. Wang, E. Babilonia, Z. Wang, Y. Jin, R. Kemp, A. Nasjletti, and W.-H. Wang Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1192 - F1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, H.-H. Chang, J. Du, C.-Y. Wang, Z. Dong, and M.-H. Wang Renal epoxyeicosatrienoic acid synthesis during pregnancy Am J Physiol Renal Physiol, January 1, 2005; 288(1): F221 - F226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Imig 20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis? Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R3 - R5. [Full Text] [PDF]
|
|
|
|
|
|
G. O. Ogungbade, L. A. Akinsanmi, H. Jiang, and A. O. Oyekan Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat Am J Physiol Renal Physiol, November 1, 2003; 285(5): F955 - F964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Hoagland, A. K. Flasch, and R. J. Roman Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats Hypertension, October 1, 2003; 42(4): 669 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ito, K. Omata, S. Ito, K. M. Hoagland, and R. J. Roman Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R822 - R830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Zhu, M. Bousamra II, D. C. Zeldin, J. R. Falck, M. Townsley, D. R. Harder, R. J. Roman, and E. R. Jacobs Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L335 - L343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ma, W. Qu, P. E. Scarborough, K. B. Tomer, C. R. Moomaw, R. Maronpot, L. S. Davis, M. D. Breyer, and D. C. Zeldin Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney J. Biol. Chem., June 18, 1999; 274(25): 17777 - 17788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, J. H. Capdevila, D. C. Zeldin, and R. L. Rosenberg Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids Mol. Pharmacol., February 1, 1999; 55(2): 288 - 295. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Imig, E. W. Inscho, P. C. Deichmann, K. M. Reddy, and J. R. Falck Afferent Arteriolar Vasodilation to the Sulfonimide Analog of 11,12-Epoxyeicosatrienoic Acid Involves Protein Kinase A Hypertension, January 1, 1999; 33(1): 408 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Wang, E. Brand-Schieber, B. A. Zand, X. Nguyen, J. R. Falck, N. Balu, and M. L. Schwartzman Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 966 - 973. [Abstract] [Full Text]
|
|
|
|
|
|
A. O. Oyekan and J. C. McGiff Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R52 - R61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Sinal, M. Miyata, M. Tohkin, K. Nagata, J. R. Bend, and F. J. Gonzalez Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation J. Biol. Chem., December 15, 2000; 275(51): 40504 - 40510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al. Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain J. Biol. Chem., June 29, 2001; 276(27): 25467 - 25479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Zeldin Epoxygenase Pathways of Arachidonic Acid Metabolism J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
